No abstract available
MeSH terms
-
Aged
-
Androgen Antagonists / administration & dosage*
-
Antineoplastic Agents, Hormonal / administration & dosage*
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Biopsy, Needle
-
Brachytherapy / methods*
-
Combined Modality Therapy / methods
-
Disease-Free Survival
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Neoplasm Invasiveness / pathology*
-
Neoplasm Staging
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / pathology*
-
Prostatic Neoplasms / therapy*
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Survival Rate
-
Treatment Outcome
Substances
-
Androgen Antagonists
-
Antineoplastic Agents, Hormonal
-
Prostate-Specific Antigen